{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:54:47Z","timestamp":1776387287471,"version":"3.51.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100017521","name":"Esteve Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s12325-023-02744-2","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T08:02:25Z","timestamp":1704528145000},"page":"1025-1045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1)"],"prefix":"10.1007","volume":"41","clinical-trial-number":[{"clinical-trial-number":"nct02982161","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Richard","family":"Langford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther M.","family":"Pogatzki-Zahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelaida","family":"Morte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Sust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Cebrecos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Vaqu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Fettiplace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shola","family":"Adeyemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"L\u00f3pez-Cedr\u00fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socorro","family":"Besc\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neus","family":"Gasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Plata-Salam\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"issue":"12","key":"2744_CR1","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1526-4637.2010.00983.x","volume":"11","author":"R Sinatra","year":"2010","unstructured":"Sinatra R. Causes and consequences of inadequate management of acute pain. Pain Med. 2010;11(12):1859\u201371.","journal-title":"Pain Med"},{"issue":"1","key":"2744_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1185\/03007995.2013.860019","volume":"30","author":"TJ Gan","year":"2014","unstructured":"Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014;30(1):149\u201360.","journal-title":"Curr Med Res Opin"},{"issue":"5\u20136","key":"2744_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/jocn.13094","volume":"25","author":"J Gregory","year":"2016","unstructured":"Gregory J, McGowan L. An examination of the prevalence of acute pain for hospitalised adult patients: a systematic review. J Clin Nurs. 2016;25(5\u20136):583\u201398.","journal-title":"J Clin Nurs"},{"issue":"Suppl 1","key":"2744_CR4","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.4103\/joacp.JOACP_51_18","volume":"35","author":"AD Kaye","year":"2019","unstructured":"Kaye AD, Urman RD, Rappaport Y, et al. Multimodal analgesia as an essential part of enhanced recovery protocols in the ambulatory settings. J Anaesthesiol Clin Pharmacol. 2019;35(Suppl 1):S40\u20135.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"6","key":"2744_CR5","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/bja\/aew381","volume":"117","author":"EMK Walker","year":"2016","unstructured":"Walker EMK, Bell M, Cook TM, Grocott MPW, Moonesinghe SR. Patient reported outcome of adult perioperative anaesthesia in the United Kingdom: a cross-sectional observational study. Br J Anaesth. 2016;117(6):758\u201366.","journal-title":"Br J Anaesth"},{"issue":"3","key":"2744_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bja.2019.05.030","volume":"123","author":"C Edgley","year":"2019","unstructured":"Edgley C, Hogg M, De Silva A, Braat S, Bucknill A, Leslie K. Severe acute pain and persistent post-surgical pain in orthopaedic trauma patients: a cohort study. Br J Anaesth. 2019;123(3):350\u20139.","journal-title":"Br J Anaesth"},{"issue":"3","key":"2744_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/10903121003760218","volume":"14","author":"M Galinski","year":"2010","unstructured":"Galinski M, Ruscev M, Gonzalez G, et al. Prevalence and management of acute pain in prehospital emergency medicine. Prehosp Emerg Care. 2010;14(3):334\u20139.","journal-title":"Prehosp Emerg Care"},{"issue":"2","key":"2744_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12630-014-0275-x","volume":"62","author":"M Tan","year":"2015","unstructured":"Tan M, Law LS, Gan TJ. Optimizing pain management to facilitate Enhanced Recovery After Surgery pathways. Can J Anaesth. 2015;62(2):203\u201318.","journal-title":"Can J Anaesth"},{"key":"2744_CR9","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2147\/JPR.S144066","volume":"10","author":"TJ Gan","year":"2017","unstructured":"Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017;10:2287\u201398.","journal-title":"J Pain Res"},{"issue":"2","key":"2744_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000588","volume":"2","author":"EM Pogatzki-Zahn","year":"2017","unstructured":"Pogatzki-Zahn EM, Segelcke D, Schug SA. Postoperative pain-from mechanisms to treatment. Pain Rep. 2017;2(2):e588.","journal-title":"Pain Rep"},{"issue":"12","key":"2744_CR11","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.apmr.2017.05.029","volume":"98","author":"JD Bier","year":"2017","unstructured":"Bier JD, Kamper SJ, Verhagen AP, Maher CG, Williams CM. Patient nonadherence to guideline-recommended care in acute low back pain. Arch Phys Med Rehabil. 2017;98(12):2416\u201321.","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"2744_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/papr.12589","volume":"18","author":"B Stessel","year":"2018","unstructured":"Stessel B, Theunissen M, Marcus MA, et al. Prevalence and predictors of patient nonadherence to pharmacological acute pain therapy at home after day surgery: a prospective cohort study. Pain Pract. 2018;18(2):194\u2013204.","journal-title":"Pain Pract"},{"issue":"3","key":"2744_CR13","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.101669","volume":"10","author":"I Callebaut","year":"2020","unstructured":"Callebaut I, Jorissen S, Pelckmans C, et al. Four-week pain profile and patient non-adherence to pharmacological pain therapy after day surgery. Anesth Pain Med. 2020;10(3):e101669.","journal-title":"Anesth Pain Med"},{"key":"2744_CR14","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/j.anclin.2017.01.018","volume":"35","author":"A Beverly","year":"2017","unstructured":"Beverly A, Kaye AD, Ljungqvist O, Urman RD. Essential elements of multimodal analgesia in Enhanced Recovery After Surgery (ERAS) guidelines. Anesthesiol Clin. 2017;35:e115\u201343.","journal-title":"Anesthesiol Clin"},{"issue":"4","key":"2744_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s40140-014-0079-0","volume":"4","author":"K Hagen","year":"2014","unstructured":"Hagen K, Iohom G. Pain management for ambulatory surgery: what is new? Curr Anesthesiol Rep. 2014;4(4):326\u201333.","journal-title":"Curr Anesthesiol Rep"},{"key":"2744_CR16","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.2147\/JPR.S208082","volume":"12","author":"C Almansa","year":"2019","unstructured":"Almansa C, Frampton CS, Vela JM, Whitelock S, Plata-Salam\u00e1n CR. Co-crystals as a new approach to multimodal analgesia and the treatment of pain. J Pain Res. 2019;12:2679\u201389.","journal-title":"J Pain Res"},{"issue":"5","key":"2744_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/13543784.2019.1612557","volume":"28","author":"N Gasc\u00f3n","year":"2019","unstructured":"Gasc\u00f3n N, Almansa C, Merlos M, et al. Co-crystal of tramadol-celecoxib: preclinical and clinical evaluation of a novel analgesic. Expert Opin Investig Drugs. 2019;28(5):399\u2013409.","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"2744_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/bcpt.13528","volume":"128","author":"K Suzuki","year":"2021","unstructured":"Suzuki K, Naito T, Tanaka H, et al. Impact of CYP2D6 activity and cachexia progression on enantiomeric alteration of plasma tramadol and its demethylated metabolites and their relationships with central nervous system symptoms in head and neck cancer patients. Basic Clin Pharmacol Toxicol. 2021;128(3):472\u201381.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2744_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s002100000266","volume":"362","author":"C Gillen","year":"2000","unstructured":"Gillen C, Haurand M, Kobelt DJ, Wnendt S. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedebergs Arch Pharmacol. 2000;362(2):116\u201321.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"26","key":"2744_CR20","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519\u201329.","journal-title":"N Engl J Med"},{"key":"2744_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4857","volume":"354","author":"A Arfe","year":"2016","unstructured":"Arfe A, Scotti L, Varas-Lorenzo C, et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016;354:i4857.","journal-title":"BMJ"},{"issue":"10","key":"2744_CR22","first-page":"CD004233","volume":"2013","author":"S Derry","year":"2013","unstructured":"Derry S, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2013;2013(10):CD004233.","journal-title":"Cochrane Database Syst Rev"},{"key":"2744_CR23","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1021\/acs.cgd.6b01848","volume":"17","author":"C Almansa","year":"2017","unstructured":"Almansa C, Merc\u00e8 R, Tesson N, Farran J, Tom\u00e0s J, Plata-Salam\u00e1n CR. Co-crystal of tramadol hydrochloride\u2212celecoxib (CTC): a novel API\u2212API co-crystal for the treatment of pain. Cryst Growth Des. 2017;17:1884\u201392.","journal-title":"Cryst Growth Des"},{"issue":"6","key":"2744_CR24","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.clinthera.2021.04.002","volume":"43","author":"J Cebrecos","year":"2021","unstructured":"Cebrecos J, Carlson JD, Encina G, et al. Celecoxib-tramadol co-crystal: a randomized 4-way crossover comparative bioavailability study. Clin Ther. 2021;43(6):1051\u201365.","journal-title":"Clin Ther"},{"key":"2744_CR25","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1021\/acs.cgd.9b00008","volume":"19","author":"A Port","year":"2019","unstructured":"Port A, Almansa C, Enrech R, Bordas M, Plata-Salam\u00e1n CR. Differential solution behavior of the new API-API co-crystal of tramadol-celecoxib (CTC) versus its constituents and their combination. Cryst Growth Des. 2019;19:3172\u201382.","journal-title":"Cryst Growth Des"},{"issue":"1","key":"2744_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/bcp.13428","volume":"84","author":"S Videla","year":"2018","unstructured":"Videla S, Lahjou M, Vaqu\u00e9 A, et al. Pharmacokinetics of multiple doses of co-crystal of tramadol-celecoxib: findings from a four-way randomized open-label phase I clinical trial. Br J Clin Pharmacol. 2018;84(1):64\u201378.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"2744_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s40268-018-0235-y","volume":"18","author":"J L\u00f3pez-Cedr\u00fan","year":"2018","unstructured":"L\u00f3pez-Cedr\u00fan J, Videla S, Burgue\u00f1o M, et al. Co-crystal of tramadol-celecoxib in patients with moderate to severe acute post-surgical oral pain: a dose-finding, randomised, double-blind, placebo- and active-controlled, multicentre, phase II trial. Drugs R D. 2018;18(2):137\u201348.","journal-title":"Drugs R D"},{"issue":"1","key":"2744_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/papr.13136","volume":"23","author":"ER Viscusi","year":"2023","unstructured":"Viscusi ER, de Leon-Casasola O, Cebrecos J, et al. Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: a phase 3, randomized, double-blind, factorial, active-and placebo-controlled trial. Pain Pract. 2023;23(1):8\u201322.","journal-title":"Pain Pract"},{"issue":"10","key":"2744_CR29","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/ejp.2021","volume":"26","author":"R Langford","year":"2022","unstructured":"Langford R, Morte A, Sust M, et al. Efficacy and safety of co-crystal of tramadol-celecoxib (CTC) in acute moderate-to-severe pain after abdominal hysterectomy: a randomized, double-blind, phase 3 trial (STARDOM2). Eur J Pain. 2022;26(10):2083\u201396.","journal-title":"Eur J Pain"},{"key":"2744_CR30","unstructured":"US Food and Drug Administration. Prescribing information, SEGLENTIS. 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/213426s000lbl.pdf. Accessed 9 Nov 2021."},{"key":"2744_CR31","unstructured":"ESTEVE Pharmaceuticals SA. Velyntra Spanish Regulatory Approval. 2023. https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/89051\/FT_89051.html. Accessed 9 Oct 2023"},{"issue":"4","key":"2744_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/sim.3495","volume":"28","author":"F Bretz","year":"2009","unstructured":"Bretz F, Maurer W, Brannath W, Posch M. A graphical approach to sequentially rejective multiple test procedures. Stat Med. 2009;28(4):586\u2013604.","journal-title":"Stat Med"},{"issue":"12","key":"2744_CR33","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1111\/bcp.13395","volume":"83","author":"S Videla","year":"2017","unstructured":"Videla S, Lahjou M, Vaqu\u00e9 A, et al. Single-dose pharmacokinetics of co-crystal of tramadol-celecoxib: results of a four-way randomized open-label phase I clinical trial in healthy subjects. Br J Clin Pharmacol. 2017;83(12):2718\u201328.","journal-title":"Br J Clin Pharmacol"},{"key":"2744_CR34","first-page":"117822182093000","volume":"14","author":"SA Reines","year":"2020","unstructured":"Reines SA, Goldmann B, Harnett M, Lu L. Misuse of tramadol in the United States: an analysis of the National Survey of Drug Use and Health 2002\u20132017. Subst Abuse. 2020;14:1178221820930006.","journal-title":"Subst Abuse"},{"issue":"2","key":"2744_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","volume":"17","author":"R Chou","year":"2016","unstructured":"Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17(2):131\u201357.","journal-title":"J Pain"},{"issue":"5","key":"2744_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4514","volume":"3","author":"CA Mikosz","year":"2020","unstructured":"Mikosz CA, Zhang K, Haegerich T, et al. Indication-specific opioid prescribing for US patients with Medicaid or private insurance, 2017. JAMA Netw Open. 2020;3(5):e204514.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2744_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/AJP.0000000000000792","volume":"36","author":"M Echeverria-Villalobos","year":"2020","unstructured":"Echeverria-Villalobos M, Stoicea N, Todeschini AB, et al. Enhanced Recovery After Surgery (ERAS): a perspective review of postoperative pain management under ERAS pathways and its role on opioid crisis in the United States. Clin J Pain. 2020;36(3):219\u201326.","journal-title":"Clin J Pain"},{"issue":"4","key":"2744_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/edt.12840","volume":"39","author":"SF Malamed","year":"2023","unstructured":"Malamed SF. Pain management following dental trauma and surgical procedures. Dent Traumatol. 2023;39(4):295\u2013303.","journal-title":"Dent Traumatol"},{"issue":"11","key":"2744_CR39","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1097\/j.pain.0000000000002254","volume":"162","author":"EM Pogatzki-Zahn","year":"2021","unstructured":"Pogatzki-Zahn EM, Liedgens H, Hummelshoj L, et al. Developing consensus on core outcome domains for assessing effectiveness in perioperative pain management: results of the PROMPT\/IMI-PainCare Delphi Meeting. Pain. 2021;162(11):2717\u201336.","journal-title":"Pain"},{"key":"2744_CR40","volume-title":"WHO analgesic ladder, in StatPearls","author":"AA Anekar","year":"2022","unstructured":"Anekar AA, Cascella M. WHO Analgesic Ladder, in StatPearls. Treasure Island, FL: StatPearls Publishing; 2022."},{"issue":"2","key":"2744_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4103\/0970-9185.94892","volume":"28","author":"H Mishra","year":"2012","unstructured":"Mishra H, Khan FA. A double-blind, placebo-controlled randomized comparison of pre and postoperative administration of ketorolac and tramadol for dental extraction pain. J Anaesthesiol Clin Pharmacol. 2012;28(2):221\u20135.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"5","key":"2744_CR42","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/j.lpm.2009.09.025","volume":"39","author":"JF Borel","year":"2010","unstructured":"Borel JF, Deschaumes C, Devoize L, et al. Treating pain after dental surgery: a randomised, controlled, double-blind trial to assess a new formulation of paracetamol, opium powder and caffeine versus tramadol or placebo [article in French]. Presse Med. 2010;39(5):e103\u201311.","journal-title":"Presse Med"},{"key":"2744_CR43","unstructured":"Janssen. Ultram (tramadol hydrochloride) prescribing information. https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/ULTRAM-pi.pdf (2023). Accessed 12 Jul 2023."},{"issue":"3","key":"2744_CR44","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pain.2004.01.004","volume":"109","author":"JR Fricke Jr","year":"2004","unstructured":"Fricke JR Jr, Hewitt DJ, Jordan DM, Fisher A, Rosenthal NR. A double-blind placebo-controlled comparison of tramadol\/acetaminophen and tramadol in patients with postoperative dental pain. Pain. 2004;109(3):250\u20137.","journal-title":"Pain"},{"key":"2744_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s10194-015-0541-5","volume":"16","author":"RA Moore","year":"2015","unstructured":"Moore RA, Gay-Escoda C, Figueiredo R, et al. Dexketoprofen\/tramadol: randomised double-blind trial and confirmation of empirical theory of combination analgesics in acute pain. J Headache Pain. 2015;16:541.","journal-title":"J Headache Pain"},{"key":"2744_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12871-016-0174-5","volume":"16","author":"RA Moore","year":"2016","unstructured":"Moore RA, McQuay HJ, Tomaszewski J, et al. Dexketoprofen\/tramadol 25 mg\/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy. BMC Anesthesiol. 2016;16:9.","journal-title":"BMC Anesthesiol"},{"issue":"3","key":"2744_CR47","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.pain.2013.09.002","volume":"155","author":"NK Singla","year":"2014","unstructured":"Singla NK, Desjardins PJ, Chang PD. A comparison of the clinical and experimental characteristics of four acute surgical pain models: dental extraction, bunionectomy, joint replacement, and soft tissue surgery. Pain. 2014;155(3):441\u201356.","journal-title":"Pain"},{"issue":"5","key":"2744_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/14656566.2020.1718651","volume":"21","author":"JV Pergolizzi","year":"2020","unstructured":"Pergolizzi JV, Magnusson P, LeQuang JA, Gharibo C, Varrassi G. The pharmacological management of dental pain. Expert Opin Pharmacother. 2020;21(5):591\u2013601.","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"2744_CR49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bjoms.2014.05.005","volume":"52","author":"MA Isiordia-Espinoza","year":"2014","unstructured":"Isiordia-Espinoza MA, de Jes\u00fas Pozos-Guill\u00e9n A, Aragon-Martinez OH. Analgesic efficacy and safety of single-dose tramadol and non-steroidal anti-inflammatory drugs in operations on the third molars: a systematic review and meta-analysis. Br J Oral Maxillofac Surg. 2014;52(9):775\u201383.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"11","key":"2744_CR50","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.5005\/jp-journals-10024-2428","volume":"19","author":"AO Akinbade","year":"2018","unstructured":"Akinbade AO, Ndukwe KC, Owotade FJ. Comparative analgesic effects of ibuprofen, celecoxib and tramadol after third molar surgery: a randomized double blind controlled trial. J Contemp Dent Pract. 2018;19(11):1334\u201340.","journal-title":"J Contemp Dent Pract"},{"issue":"4","key":"2744_CR51","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.119156","volume":"11","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Kaplan LA, Khan S, et al. Full opioid agonists and tramadol: pharmacological and clinical considerations. Anesth Pain Med. 2021;11(4): e119156.","journal-title":"Anesth Pain Med"},{"key":"2744_CR52","unstructured":"Health Products Regulatory Authority. Summary of Product Characteristics, Zydol 50 mg Hard Capsules. https:\/\/www.hpra.ie\/img\/uploaded\/swedocuments\/Licence_PA2242-005-001_18022022162405.pdf (2022). Accessed 13 Nov 2023."},{"key":"2744_CR53","unstructured":"Pfizer Inc. CELEBREX (celecoxib) capsule: highlights of prescribing information. http:\/\/labeling.pfizer.com\/showlabeling.aspx?id=793 (2021) Accessed 7 Aug 2021."},{"issue":"2","key":"2744_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023715","volume":"9","author":"C Gay-Escoda","year":"2019","unstructured":"Gay-Escoda C, Hanna M, Montero A, et al. Tramadol\/dexketoprofen (TRAM\/DKP) compared with tramadol\/paracetamol in moderate to severe acute pain: results of a randomised, double-blind, placebo and active-controlled, parallel group trial in the impacted third molar extraction pain model (DAVID study). BMJ Open. 2019;9(2):e023715.","journal-title":"BMJ Open"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02744-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02744-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02744-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T18:14:02Z","timestamp":1708452842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02744-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02744-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Richard Langford has received fees from Pfizer, Eli Lilly, Compass, GSK, Avenue Therapeutics, MedinCell, Heron, Camurus, BioQ Pharma, Mundipharma, Gr\u00fcnenthal GmbH, Gr\u00fcnenthal Ltd and Syntetica for consultancy and speaker activities, and travel support from ESTEVE. Esther M. Pogatzki-Zahn received financial support for research activities, advisory board activities and lecture fees from Gr\u00fcnenthal, Medtronic, Mundipharma, and Novartis; she also receives scientific support from the German Research Foundation (DFG), the Federal Ministry of Education and Research (BMBF), the Federal Joint Committee (G-BA) and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 777500. This Joint Undertaking receives support from the European Union\u2019s Horizon 2020 Research and Innovation program and the European Federation of Pharmaceutical Industries and Associations. All money went to the institutions (WWU\/UHM) where Esther M. Pogatzki-Zahn is employed. Adelaida Morte, Mariano Sust, Jes\u00fas Cebrecos, Anna Vaqu\u00e9, Esther Ortiz, and Neus Gasc\u00f3n are employees of ESTEVE Pharmaceuticals. Socorro Besc\u00f3s\u2019s institution was paid commercial fees from Mundipharma Research GmbH & Co. KG for work on the study. Carlos Plata-Salam\u00e1n was an employee of ESTEVE Pharmaceuticals and has pending or issued patents relevant to CTC. James Fettiplace and Shola Adeyemi were employees of Mundipharma Research Limited at the time of study. Jos\u00e9 Luis L\u00f3pez-Cedr\u00fan has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the local ethics committee for each country and\/or study site; the ethics committees included in this study are listed in the Supplementary Methods S1. The principal investigator was from Spain, and the Spanish ethics committee was the Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica con Medicamentos del Hospital Universitario de la Princesa (Madrid), resolution No. 20\/17 of 10 November 2016. All patients provided written informed consent during the screening period of the study (i.e. before surgery). The study was conducted in compliance with the Declaration of Helsinki and Good Clinical Practice guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}